Supha Pharmachem Ltd Q2 FY26 results press release summary

Results press release of 17 Nov 2025, summarised by AI from the filing.

No forward guidance was given in the release.

Key takeaways

1. Guidance No forward guidance was given in the release.
2. Change Board reinforced with appointment of Mr. Rambhajan Vishwakarma and Mr. Vignesh Laxman Gawde.
3. Driver Operational discipline and business expansion drove consolidated performance.
4. Risk No risks were acknowledged in the release.

Original filing on BSE

Supha Pharmachem Ltd earnings call, investor presentation and press release summaries

• Q2 FY26: Results press release (17 Nov 2025)